Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Clontech_Laboratories
|
| gptkbp:CEO |
gptkb:Koichi_Nakao
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:focusArea |
genomics
molecular biology cell and gene therapy |
| gptkbp:founded |
2002
|
| gptkbp:headquartersLocation |
gptkb:Kusatsu,_Shiga,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Takara Bio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:languageOfWork |
English
Japanese |
| gptkbp:numberOfEmployees |
over 1,500
|
| gptkbp:operatesIn |
global
|
| gptkbp:parentCompany |
gptkb:Takara_Holdings
|
| gptkbp:products |
instruments
gene therapy reagents Nucleic acid purification kits PCR enzymes |
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stockSymbol |
4974
|
| gptkbp:subsidiary |
gptkb:Clontech_Laboratories
|
| gptkbp:technology |
gptkb:NucleoSpin_purification_kits
gptkb:PrimeScript_reverse_transcriptase gptkb:SMARTer_cDNA_synthesis |
| gptkbp:website |
https://www.takara-bio.com/
|
| gptkbp:bfsParent |
gptkb:Thermo_Fisher_Scientific
|
| gptkbp:bfsLayer |
6
|